Posterior reversible encephalopathy syndrome during systemic lupus erythematosus:: four new cases and review of the literature

被引:72
作者
Leroux, G. [1 ]
Sellam, J. [1 ]
Costedoat-Chalumeau, N. [1 ]
Huong, D. Le Thi [1 ]
Combes, A. [2 ]
Tieulie, N. [1 ]
Haroche, J. [1 ]
Amoura, Z. [1 ]
Nieszkowska, A. [2 ]
Chastre, J. [2 ]
Dormont, D. [3 ]
Piette, J-C [1 ]
机构
[1] CHU Pitie Salpetriere, Dept Internal Med, F-75013 Paris, France
[2] CHU Pitie Salpetriere, Dept Intens Care Unit, F-75013 Paris, France
[3] CHU Pitie Salpetriere, Dept Neuroradiol, F-75013 Paris, France
关键词
anti-phospholipid syndrome; hypertensive encephalopathy; posterior reversible encephalopathy syndrome; systemic lupus erythematosus;
D O I
10.1177/0961203307085405
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Posterior reversible encephalopathy syndrome (PRES) associates various neurological manifestations (headaches, seizures, altered mental status, cortical blindness, focal neurological deficits, vomiting) and transient changes on neuroimaging consistent with cerebral edema. Posterior reversible encephalopathy syndrome mainly occurs in the setting of hypertension, eclampsia, renal failure and/or use of immunosuppressive drugs. We report four cases of PRES complicating systemic lupus erythematosus (SLE). In all our cases, renal involvement and hypertension were present. Neurological symptoms were typical. Magnetic resonance imaging showed posterior cerebral edema and in one case hemorrhagic complication. With symptomatic treatment and immunosuppressor withdrawal when they were previously used, symptoms fully resolved within 15 days in all cases, but one who had only partial regression related to cerebral hemorrhage. Including our cases, we reviewed a total of 46 patients with SLE and PRES. Their clinical and radiological presentation was not specific. The peculiar role of SLE itself in the occurrence of PRES was not clear, since hypertension (95%), renal involvement (91%), recent onset of immunosuppressive drugs (54%) and/or recent treatment with high intravenous dose of steroids (43%) were often present. The hypertension and other worsening factors should be treated. Finally, the evolution of this clinical and radiological spectacular syndrome is generally rapidly favorable.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 35 条
  • [1] Posterior leukoencephalopathy without severe hypertension - Utility of diffusion-weighted MRI
    Ay, H
    Buonanno, FS
    Schaefer, PW
    Le, DA
    Wang, B
    Gonzalez, RG
    Koroshetz, WJ
    [J]. NEUROLOGY, 1998, 51 (05) : 1369 - 1376
  • [2] Bartynski WS, 2006, AM J NEURORADIOL, V27, P2179
  • [3] MAGNETIC-RESONANCE-IMAGING OF CENTRAL-NERVOUS-SYSTEM LESIONS IN PATIENTS WITH LUPUS-ERYTHEMATOSUS - CORRELATION WITH CLINICAL REMISSION AND ANTINEUROFILAMENT AND ANTICARDIOLIPIN ANTIBODY-TITERS
    BELL, CL
    PARTINGTON, C
    ROBBINS, M
    GRAZIANO, F
    TURSKI, P
    KORNGUTH, S
    [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (04): : 432 - 441
  • [4] Progressive multifocal leukoencephalopathy in rheumatic diseases - Evolving clinical and pathologic patterns of disease
    Calabrese, Leonard H.
    Molloy, Eamonn S.
    Huang, DeRen
    Ransohoff, Richard M.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (07): : 2116 - 2128
  • [5] Reversible posterior leucoencephalopathy in systemic lupus
    Caminal-Montero, L
    Trapiella-Martínez, L
    Suárez-Casado, H
    García-García, J
    [J]. MEDICINA CLINICA, 2005, 125 (18): : 719 - 719
  • [6] Posterior reversible encephalopa thy syndrome:: Some case reports
    Casali-Rey, JI
    Dávalos, EG
    López-Amalfara, A
    Julio-Muñoz, D
    Pagano, MA
    [J]. REVISTA DE NEUROLOGIA, 2003, 37 (03) : 224 - 227
  • [7] Casey SO, 2000, AM J NEURORADIOL, V21, P1199
  • [8] Reversible posterior leukoencephalopathy in systemic lupus erythematosus with thrombotic thrombocytopenic purpura
    Cassano, Gustavo
    Gongora, Vanina
    Zunino, Alfredo
    Roverano, Susana
    Paira, Sergio
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2007, 13 (01) : 55 - 57
  • [9] 31-year-old woman with confusion and labile behavior
    Dy, GK
    Swaroop, VS
    [J]. MAYO CLINIC PROCEEDINGS, 2002, 77 (06) : 557 - 560
  • [10] Foocharoen Chingching, 2006, Journal of the Medical Association of Thailand, V89, P1029